0
Sign In  | Subscribe

Hypertension Collection
 21-37 of 37 Articles
ACP Journal Club |  17 November 2009
Tight BP control reduced left ventricular hypertrophy in nondiabetic patients with hypertension
PDFPDF
Finlay A. McAlister, MD
Ann Intern Med. 2009;151(10):JC5-7. doi:10.7326/0003-4819-151-10-200911170-02007
ACP Journal Club |  18 August 2009
Review: Aldosterone blockade reduces mortality in patients with left ventricular dysfunction
PDFPDF
Peter Liu, MD
Ann Intern Med. 2009;151(4):JC2-9. doi:10.7326/0003-4819-151-4-200908180-02009
ACP Journal Club |  18 August 2009
Review: Combining 2 classes of blood pressure–lowering drugs has an approximately additive effect on systolic blood pressure
PDFPDF
Alena Shantsila, MD; Gregory Y.H. Lip, MD
Ann Intern Med. 2009;151(4):JC2-11. doi:10.7326/0003-4819-151-4-200908180-02011
ACP Journal Club |  19 May 2009
What kind of randomized trials do patients and clinicians need?
PDFPDF
Merrick Zwarenstein, MBBCh, MSc; Shaun Treweek, PhD
Ann Intern Med. 2009;150(10):JC5-2. doi:10.7326/0003-4819-150-10-200905190-02002
ACP Journal Club |  19 May 2009
Benazepril plus amlodipine reduced cardiovascular risk more than benazepril plus hydrochlorothiazide
PDFPDF
Simon W. Rabkin, MD
Ann Intern Med. 2009;150(10):JC5-8. doi:10.7326/0003-4819-150-10-200905190-02008
ACP Journal Club |  19 May 2009
Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fraction
PDFPDF
Justin A. Ezekowitz, MD; Finlay A. McAlister, MD
Ann Intern Med. 2009;150(10):JC5-10. doi:10.7326/0003-4819-150-10-200905190-02010
ACP Journal Club |  17 February 2009
Telmisartan did not reduce a composite of CV death, MI, HF, or stroke in high-risk patients intolerant to ACE inhibitors
PDFPDF
Robin J. Taylor, MD
Ann Intern Med. 2009;150(4):JC2-6. doi:10.7326/0003-4819-150-4-200902170-02006
ACP Journal Club |  17 February 2009
Telmisartan did not prevent recurrent stroke or major cardiovascular events
PDFPDF
Michael A. Sloan, MD, MS
Ann Intern Med. 2009;150(4):JC2-9. doi:10.7326/0003-4819-150-4-200902170-02009
ACP Journal Club |  17 February 2009
Intensive insulin therapy reduced long-term risk for incident hypertension in type 1 diabetes
PDFPDF
Apostolos Tsapas, MD, PhD
Ann Intern Med. 2009;150(4):JC2-12. doi:10.7326/0003-4819-150-4-200902170-02012
ACP Journal Club |  20 January 2009
Applying evidence: What’s the next action?
PDFPDF
Paul Glasziou, MD
Ann Intern Med. 2009;150(2):JC1-2. doi:10.7326/0003-4819-150-2-200901200-02002
ACP Journal Club |  16 December 2008
Benefits of tight blood pressure control to prevent diabetes complications were not sustained
PDFPDF
Eoin P. O’Sullivan, MD; Sean F. Dinneen, MD
Ann Intern Med. 2008;149(12):JC6-5. doi:10.7326/0003-4819-149-12-200812160-02005
ACP Journal Club |  16 December 2008
A combination of telmisartan and ramipril increased renal outcomes in vascular disease or diabetes
PDFPDF
Arsh K. Jain, MD; Matthew A. Weir, MD
Ann Intern Med. 2008;149(12):JC6-7. doi:10.7326/0003-4819-149-12-200812160-02007
ACP Journal Club |  21 October 2008
An intervention involving pharmacist care via the Web improved blood pressure control in uncontrolled hypertension
PDFPDF
Tejas V. Patel, MD, MPH
Ann Intern Med. 2008;149(4):JC4-11. doi:10.7326/0003-4819-149-8-200810210-02011
ACP Journal Club |  21 October 2008
Review: Spot protein–creatinine ratio has moderate diagnostic performance for proteinuria in pregnant women with hypertension
PDFPDF
Christopher J. Robinson, MD
Ann Intern Med. 2008;149(4):JC4-14. doi:10.7326/0003-4819-149-8-200810210-02014
ACP Journal Club |  16 September 2008
Metoprolol prevented myocardial infarction but increased risk for stroke and death after noncardiac surgery
PDFPDF
Robert Roberts, MD
Ann Intern Med. 2008;149(6):JC3-4. doi:10.7326/0003-4819-149-6-200809160-02004
ACP Journal Club |  19 August 2008
Antihypertensive therapy with indapamide and perindopril reduced mortality in patients ≥ 80 years
PDFPDF
William W. Hung, MD, MPH; Rosanne M. Leipzig, MD, PhD
Ann Intern Med. 2008;149(4):JC2-10. doi:10.7326/0003-4819-149-4-200808190-02010
ACP Journal Club |  Jan/Feb 2000
Controlled- and extended-release metoprolol reduced mortality in congestive heart failure
PDFPDF
Robert S. McKelvie, MSc, MD, PhD
Ann Intern Med. 2000;132(1):3. doi:10.7326/ACPJC-2000-133-1-003
Advertisement

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)